2022. Prevalence, treatment, and 1-year outcomes of heart failure with mid-range ejection fraction. Biomedical Research and Therapy. 9, 8 (Aug. 2022), 5209–5215. DOI:https://doi.org/10.15419/bmrat.v9i8.758.